Phase I Dose Escalation Study of Pirarubicin in Combination with Cyclophosphamide in Breast Cancer

被引：0
|
作者：
Sakata, M. [1 ]
Jinno, H. [1 ]
Hayashida, T. [1 ]
Takahashi, M. [1 ]
Sato, T. [1 ]
Seki, H. [1 ]
Shimada, K. [1 ]
Nishiya, S. [1 ]
Kitagawa, Y. [1 ]
机构：
[1] Keio Univ, Sch Med, Tokyo, Tokyo, Japan
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P5-10-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-10-13
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase I study of sunitinib in combination with metronomic dosing of cyclophosphamide and methotrexate in patients with metastatic breast cancer
    Lyandres, L.
    Melisko, M.
    Moasser, M.
    Goga, A.
    Park, J. W.
    Rugo, H. S.
    CANCER RESEARCH, 2009, 69 (02) : 286S - 286S
  • [32] Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer
    P A Vasey
    H Roché
    D Bisset
    C Terret
    L Vernillet
    A Riva
    C Ramazeilles
    N Azli
    S B Kaye
    C J Twelves
    British Journal of Cancer, 2002, 87 : 1072 - 1078
  • [33] Phase I study of docetaxel in combination with cyclophosphamide as first-line chemotherapy for metastatic breast cancer
    Vasey, PA
    Roché, H
    Bisset, D
    Terret, C
    Vernillet, L
    Riva, A
    Ramazeilles, C
    Azli, N
    Kaye, SB
    Twelves, CJ
    BRITISH JOURNAL OF CANCER, 2002, 87 (10) : 1072 - 1078
  • [34] A phase I dose escalation study of doxorubicin in combination with pemetrexed (Alimta®, multitargeted antifolate).
    Hughes, AN
    Lind, M
    Azzabi, A
    Todd, R
    Plummer, R
    Margetts, J
    Fishwick, K
    Hancock, M
    Verrill, M
    Dark, G
    Calvert, H
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 286 - 286
  • [35] Dose-finding phase I and pharmacokinetic study of capecitabine (xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer
    Saji, Shigehira
    Toi, Masakazu
    Morita, Satoshi
    Iwata, Hiroji
    Ito, Yoshinori
    Ohno, Shinji
    Kobayashi, Tadashi
    Hozumi, Yasuo
    Sakamoto, Junichi
    ONCOLOGY, 2007, 72 (5-6) : 330 - 337
  • [36] Safety of NOX66 in Combination With Palliative Dose Radiotherapy - A Phase I Dose Escalation Study
    Minns, Ian
    Messina, Marinella
    Kelly, Graham
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 166 - 166
  • [37] Interim analysis of a phase I dose escalation study of topical bexarotene in women at high risk for breast cancer
    Thomas, Parijatham S.
    Patel, Anisha B.
    Liu, Diane
    Lee, J. Jack
    Khan, Seema
    Muzzio, Miguel
    Contreras, Alejandro
    Vornik, Lana
    Dimond, Eileen P.
    Perloff, Marjorie
    Heckman-Stoddard, Brandy
    Brown, Powel H.
    CANCER RESEARCH, 2021, 81 (04)
  • [38] A randomized phase I Bayesian dose escalation design for the combination of anti-cancer drugs
    Dejardin, David
    Lesaffre, Emmanuel
    Hamberg, Paul
    Verweij, Jaap
    PHARMACEUTICAL STATISTICS, 2014, 13 (03) : 196 - 207
  • [39] Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study
    Awada, A.
    Albanell, J.
    Canney, P. A.
    Dirix, L. Y.
    Gil, T.
    Cardoso, F.
    Gascon, P.
    Piccart, M. J.
    Baselga, J.
    BRITISH JOURNAL OF CANCER, 2008, 98 (09) : 1500 - 1507
  • [40] Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study
    A Awada
    J Albanell
    P A Canney
    L Y Dirix
    T Gil
    F Cardoso
    P Gascon
    M J Piccart
    J Baselga
    British Journal of Cancer, 2008, 98 : 1500 - 1507
12345